However, the activation of LXR promoted the transcription of liver lipid synthesis related genes like SREBF1, FASN, SCD, and ACACA, leading to liver steatosis and hyperlipidemia (12, 60). The gene discussed is SREBF1; the disease is hyperlipidemia.